DUBLIN--(BUSINESS WIRE)--The "Global Markets for Advanced Drug Delivery Systems - Market Trend & Forecast 2017 - 2022" report has been added to Research and Markets' offering.
The market will grow at a healthy pace in the next few years because of continuous discovery and development of new drug delivery systems in research-based pharmaceutical companies, which is again a reason for strategic collaborations and profitable partnerships between pharmaceutical companies.
North America has the largest market for advanced drug delivery systems, followed by Europe. These regions have a well-established pharmaceutical industry which fuel the growth of the advanced drug delivery market. The Asian market is expected to double its growth in coming years because of developments in pharmaceutical and healthcare industries.
The global advanced drug delivery market is driven by development of new drugs and biologics. Also, advances in understanding human biology and diseases, R & D spending, non-traditional administration routes and new and emerging technologies fuel this market.
The product recalls of advanced drug delivery products is a major factor that is hindering the growth of this market along with raised concerns on R&D expenditure for development of such products.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Market Overview
4. Porters Five Force Analysis
5. Market Segmentation
6. Competitive Landscape
7. Company Profiles
- 3M Company
- Abbott Laboratories
- Amgen Inc.
- Astellas Pharma
- Astrazeneca
- Baxter International Inc.,
- Bayer Healthcare Pharmaceuticals
- Boston Scientific
- Celgene Corporation
- Glaxosmithkline PLC
- Merck & Co
- Novartis
- Pfizer
- Roche Holding
- Sanofi SA
- Teva Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/6h5thd/global_markets
